Takis
Business Services · Italy · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Via Di Castel Romano 100, Latium, 00128,...Website
www.takisbiotech.itRevenue
$5.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Takis
Takis is a Biotech Company created by a group of scientists from Merck Research Laboratories (MRL). The group has more than 15 years of experience and an established track record in drug discovery in Oncology and is recognized for the conception and implementation of a number of innovative technologies. One of the main assets of Takis is the expertise in in vivo electro-gene-transfer, which can be used for a variety of clinically useful applications, from vaccine development to somatic gene therapy. Takis pipeline include four Cancer Vaccine candidates based on this technology. Takis is also actively involved in the generation of humanized monoclonal antibodies for use in Oncology and Infectious Diseases.Explore more
Takis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Takis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Takis
Takis, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Takis recently announced quarterly report
Check if Takis has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Takis launches new products
Check out if Takis is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Takis has new funding data
Click to see if Takis had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Takis
Find 2 more new buyers
Company Profile Activity
Activity Insights
Takis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Takis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Takis.
Takis Tech Stack
Takis News & Media
Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals
STONY BROOK, N.Y. & ROME--(BUSINESS WIRE)-- #COVID19--Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company” or “we/our”) today announced with its COVID-19 vaccine development partner Takis Biotech (“Takis”) that the first injections of the DNA vaccine candidates against the Spike protein (product of the S gene) of the SARS-CoV-2 virus, cause of the COVID-19 disease, have produced neutralizing antibodies in test animals. The studies were completed at the renowned Lazzaro SpApplied DNA Ships COVID-19 LinearDNA™ Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing
STONY BROOK, N.Y. & ROME--(BUSINESS WIRE)---- $APDN #COVID19--Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, today announced that it has completed design qualification, production and shipment of five COVID-19 vaccine candidates to Italy-basedApplied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate
STONY BROOK, N.Y., & ROME--(BUSINESS WIRE)--Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, and Takis Biotech (“Takis”), a company focused on the development of cancer vaccines and founded by scientists from Merck Research Laboratories, today anApplied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-clinical Models
STONY BROOK, N.Y.--(BUSINESS WIRE)--Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA”) today announced that its COVID-19 collaboration partner, Takis Biotech, a Rome, Italy-based a company focused on the development of cancer vaccines founded by scientists from Merck Research Laboratories, has received approval from the Italy’s Ministry of Health to begin a pre-clinical trial of a COVID-19 vaccine candidate. As announced by Applied DNA on March 2, 2020, the vaccine is one of four PCR-prod
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Takis
Sign Up For FreeTo access detailed company insights
Takis is a Biotech Company created by a group of scientists from Merck Research Laboratories (MRL). The group has more than 15 years of experience and an established track record in drug discovery in Oncology and is recognized for the conception and implementation of a number of innovative technologies. One of the main assets of Takis is the expert... Read More
